Quadrant Capital Group LLC Has $212,000 Holdings in Express Scripts Holding Company (ESRX)
Quadrant Capital Group LLC cut its stake in Express Scripts Holding Company (NASDAQ:ESRX) by 8.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,732 shares of the company’s stock after selling 343 shares during the period. Quadrant Capital Group LLC’s holdings in Express Scripts Holding were worth $212,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently modified their holdings of ESRX. Burt Wealth Advisors increased its position in Express Scripts Holding by 11.4% in the second quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after buying an additional 174 shares during the period. CKW Financial Group increased its position in Express Scripts Holding by 20.0% in the second quarter. CKW Financial Group now owns 1,800 shares of the company’s stock worth $115,000 after buying an additional 300 shares during the period. TrimTabs Asset Management LLC acquired a new stake in Express Scripts Holding in the first quarter worth $121,000. IHT Wealth Management LLC increased its position in Express Scripts Holding by 8.1% in the first quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock worth $128,000 after buying an additional 145 shares during the period. Finally, First Personal Financial Services increased its position in Express Scripts Holding by 199.1% in the second quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock worth $134,000 after buying an additional 1,400 shares during the period. 88.69% of the stock is currently owned by hedge funds and other institutional investors.
ESRX has been the topic of a number of research analyst reports. BidaskClub lowered Express Scripts Holding from a “hold” rating to a “sell” rating in a report on Wednesday, July 12th. Needham & Company LLC initiated coverage on Express Scripts Holding in a report on Friday, July 21st. They set a “hold” rating on the stock. Morgan Stanley raised their price target on Express Scripts Holding from $52.00 to $57.00 and gave the company an “underweight” rating in a report on Thursday, August 10th. Jefferies Group LLC set a $72.00 price target on Express Scripts Holding and gave the company a “buy” rating in a report on Tuesday, August 29th. Finally, Robert W. Baird reissued a “hold” rating and set a $56.00 price target on shares of Express Scripts Holding in a report on Friday, September 1st. Six research analysts have rated the stock with a sell rating, eleven have assigned a hold rating, seven have given a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $69.09.
Shares of Express Scripts Holding Company (NASDAQ:ESRX) opened at 57.21 on Wednesday. The company has a market capitalization of $33.04 billion, a P/E ratio of 9.93 and a beta of 0.88. The firm has a 50 day moving average price of $61.90 and a 200 day moving average price of $62.41. Express Scripts Holding Company has a one year low of $56.62 and a one year high of $77.50.
Express Scripts Holding (NASDAQ:ESRX) last posted its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.71 by $0.02. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The firm had revenue of $25.35 billion during the quarter, compared to analyst estimates of $25.52 billion. During the same period last year, the company posted $1.57 EPS. The business’s quarterly revenue was up .5% on a year-over-year basis. On average, equities research analysts predict that Express Scripts Holding Company will post $6.99 EPS for the current fiscal year.
In related news, VP Everett Neville sold 1,163 shares of the business’s stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $61.48, for a total value of $71,501.24. Following the completion of the sale, the vice president now directly owns 18,232 shares of the company’s stock, valued at approximately $1,120,903.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Phyllis S. Anderson sold 578 shares of the business’s stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $63.13, for a total value of $36,489.14. Following the completion of the sale, the vice president now directly owns 10,530 shares of the company’s stock, valued at $664,758.90. The disclosure for this sale can be found here. Over the last three months, insiders sold 5,641 shares of company stock valued at $357,317. Corporate insiders own 0.68% of the company’s stock.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.